The invention relates to derivatives of the pyrazoyl[1,2,4]triazolo[4,3-α]quinoxaline according to formula (1), or of its analog in the form of the pyrazolyl-substituted tetrazolo[1,5-α]quinoxalines according to formula (2). The substances according to formula 1 or 2, in this form or in the form of their pharmaceutically acceptable salts, are suitable as active agents, especially as adenosine receptor ligands.
                            该发明涉及公式(1)的
吡唑基[1,2,4]三唑并[4,3-α]
喹喔啉或其类似物的
吡唑基取代的
四唑并[1,5-α]
喹喔啉的衍
生物。公式1或2的物质,在这种形式或其药学上可接受的盐的形式中,可用作活性剂,特别是作为
腺苷受体
配体。